Joshua Cohen & Dr. Sabrina Paganoni - New ALS Treatment

September 23, 2020

Daily Grind Logo 300x300

Joshua Cohen, Founder and CEO of Amylyx Pharmaceuticals, and Dr. Sabrina Paganoni from Mass General in Boston discuss a new ALS treatment that slows down the progressive disease and provides a big step toward some day finding a cure.